Treatment with glatiramer acetate delays conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome: subgroup analyses

被引:0
|
作者
Comi, Giancarlo [1 ,2 ]
Carra, Adriana [3 ]
Fazekas, Franz [4 ]
Rieckmann, Peter [5 ]
Bajenaru, O. [6 ]
Hillert, Jan [7 ]
Elovaara, Irina [8 ]
Young, Carolyn [9 ]
Wynn, Daniel [10 ]
King, John [11 ]
Lubetzki, Catherine [12 ]
Hartung, Hans-Peter [13 ]
Myhr, Kjell-Morten [14 ]
Montalban, Xavier [15 ]
Komoly, Samuel [16 ]
Filippi, Massimo [17 ]
机构
[1] Ist Sci San Raffaele, I-20132 Milan, Italy
[2] Univ Vita Salute, Dept Neurol, Milan, Italy
[3] Hosp Britan, Buenos Aires, DF, Argentina
[4] Med Univ Graz, Graz, Afghanistan
[5] Univ Bristish Columbia & Vancouver Coastal Hlth, Vancouver, BC, Canada
[6] Carol Davila Univ Med & Pharm, Bucharest, Romania
[7] Karolinska Univ Hosp, Stockholm, Sweden
[8] Univ Tampere, FIN-33101 Tampere, Finland
[9] Walton Ctr Neurol & Neurosurg, Liverpool, Merseyside, England
[10] Neurol Multiple Sclerosis Ctr, Northbrook, IL USA
[11] Royal Melbourne Hosp, Melbourne, Vic, Australia
[12] Hop La Pitie Salpetriere, Paris, France
[13] Univ Dusseldorf, Dusseldorf, Germany
[14] Haukeland Hosp, N-5021 Bergen, Norway
[15] Hosp Univ Vall dHebron, Barcelona, Spain
[16] Univ Pecs, Budapest, Hungary
[17] Ist Sci San Raffaele, I-20132 Milan, Italy
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S38 / S38
页数:1
相关论文
共 50 条
  • [31] Relevance of the study of oligoclonal bands as a prognostic factor of the conversion of clinically isolated syndrome into clinically definite multiple sclerosis in daily practice
    Dionet, Elsa
    Taithe, Frederic
    Lauxerois, Michel
    Fogli, Anne
    Clavelou, Pierre
    MULTIPLE SCLEROSIS, 2008, 14 : S119 - S119
  • [32] Prognostic factors for conversion to clinically definite multiple sclerosis in an Italian cohort of subjects with clinically isolated syndromes
    Portaccio, E.
    Lepore, V.
    Hakiki, B.
    Zipoli, V.
    Comi, G.
    Trojano, M.
    Amato, M. P.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S44 - S44
  • [33] Cerebral and Spinal MRI Examination in patients with Clinically Isolated Syndrome and Definite Multiple Sclerosis
    Sailer, M.
    Fazekas, F.
    Gass, A.
    Kappos, L.
    Radue, E. -W.
    Rieckmann, P.
    Toykas, K.
    Wiendl, H.
    Bendszus, M.
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 2008, 180 (11): : 994 - 1001
  • [34] Early treatment to prevent conversion of clinically isolated syndrome to clinically defined multiple sclerosis: a Cochrane metanalysis
    Clerico, Marinella
    Faggiano, Fabrizio
    Rice, George P.
    Palace, Jacqueline
    Tintore, Mar
    Durelli, Luca
    MULTIPLE SCLEROSIS, 2008, 14 : S61 - S61
  • [35] Vitamin D deficiency predicts early conversion of clinically isolated syndrome to clinically definite multiple sclerosis: A preliminary Egyptian study
    Shaheen, H.
    Sobhy, S.
    Ibrahim, L.
    Abdelaziz, H.
    Taha, M.
    Daker, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 653 - 653
  • [36] Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes
    Kappos, L.
    Polman, C. H.
    Freedman, M. S.
    Edan, G.
    Hartung, H. P.
    Miller, D. H.
    Montalban, X.
    Barkhof, F.
    Bauer, L.
    Jakobs, P.
    Pohl, C.
    Sandbrink, R.
    NEUROLOGY, 2006, 67 (07) : 1242 - 1249
  • [37] Brain lesion number and spinal cord lesions in clinically isolated syndrome patients and the risk for clinically definite multiple sclerosis
    Swanton, L. K.
    Fernando, K. T.
    Dalton, C. M.
    Miszkiel, K. A.
    Plant, G. T.
    Thompson, A. J.
    Miller, D. H.
    MULTIPLE SCLEROSIS, 2007, 13 : S78 - S78
  • [38] Prognostic factors for the early development of clinically definite multiple sclerosis in patients with clinically isolated syndromes
    Martinelli, V.
    Dalla Costa, G.
    Di Maggio, G.
    Colombo, B.
    Dalla Libera, D.
    Leocani, L.
    Furlan, R.
    Filippi, M.
    Comi, G.
    JOURNAL OF NEUROLOGY, 2013, 260 : S129 - S130
  • [39] Benefit-Risk Analysis of Glatiramer Acetate for Relapsing-Remitting and Clinically Isolated Syndrome Multiple Sclerosis
    Qizilbash, Nawab
    Mendez, Ignacio
    Sanchez-de la Rosa, Rainel
    CLINICAL THERAPEUTICS, 2012, 34 (01) : 159 - 176
  • [40] Glatiramer Acetate A Review of its Use in Relapsing-Remitting Multiple Sclerosis and in Delaying the Onset of Clinically Definite Multiple Sclerosis
    Carter, Natalie J.
    Keating, Gillian M.
    DRUGS, 2010, 70 (12) : 1545 - 1577